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ABSTRACT
Rationale Sensitive outcome measures applicable in
different centres to quantify and track early pulmonary
abnormalities in infants with cystic ﬁbrosis (CF) are
needed both for clinical care and interventional trials.
Chest CT has been advocated as such a measure yet there
is no validated scoring system in infants.
Objectives The objectives of this study were to
standardise CT data collection across multiple sites;
ascertain the incidence of bronchial dilatation and air
trapping in newborn screened (NBS) infants with CF at
1 year; and assess the reproducibility of Brody-II, the most
widely used scoring system in children with CF, during
infancy.
Methods A multicentre observational study of early
pulmonary lung disease in NBS infants with CF at age
1 year using volume-controlled chest CT performed under
general anaesthetic.
Main results 65 infants with NBS-diagnosed CF had
chest CT in three centres. Small insigniﬁcant variations in
lung recruitment manoeuvres but signiﬁcant centre
differences in radiation exposures were found. Despite
experienced scorers and prior training, with the exception
of air trapping, inter- and intraobserver agreement on
Brody-II score was poor to fair (eg, interobserver total
score mean (95% CI) κ coefﬁcient: 0.34 (0.20 to 0.49)).
Only 7 (11%) infants had a total CT score ≥12 (ie, ≥5%
maximum possible) by either scorer.
Conclusions In NBS infants with CF, CT changes were
very mild at 1 year, and assessment of air trapping was
the only reproducible outcome. CT is thus of questionable
value in infants of this age, unless an improved scoring
system for use in mild CF disease can be developed.
INTRODUCTION
Widespread newborn screening for cystic ﬁbrosis
(CF) has resulted in early diagnosis and the poten-
tial for early intervention before changes in lung
function and structure become irreversible.
Sensitive outcome measures to quantify and track
early abnormalities in infants and young children
are needed both for clinical care and interventional
trials. However, early intervention studies are likely
to be of considerable duration and involve treat-
ments with possible side effects. Such studies
should therefore not be undertaken without ensur-
ing that any risk is justiﬁed by a reasonable likeli-
hood of obtaining useful information.
CT of the chest has been advocated as a sensitive
surrogate measure of early lung disease,1–4 since
bronchiectasis and gas trapping have been detected
in newborn screened (NBS) infants with CF,5–7 and
a recent international seminar concluded that chest
CTwas a useful outcome for interventional trials in
very young children with CF.8 Despite increasing
publications in this ﬁeld,5–7 9 10 the challenges in
obtaining standardised chest CTs at consistent lung
volumes11 with acceptable radiation exposure in
infants, and also identifying a reproducible scoring
system, sensitive to very mild lung disease, which
can quantify severity of changes in NBS infants with
CF, have received relatively little attention. The
Brody-II CT score12 is the most widely used and
validated scoring system in CF2 4 13–16 which quan-
tiﬁes lung disease objectively in school-aged children
with good interobserver agreement,2 12 but its use-
fulness in young infants with mild disease has not
been established. Thus it is difﬁcult to know
whether changes identiﬁed in this population repre-
sent disease, normal variation or experimental error.
A longitudinal observational study of lung func-
tion and structure in NBS infants with CF by the
London CF Collaboration (LCFC)17 18 in which
volumetric CT scans were obtained at 1 year of age,
provided the opportunity to explore these chal-
lenges. Before starting the study, discussions were
held with international experts, including those
from the Australian Respiratory Early Surveillance
Key messages
What is the key question?
Is chest CT a reliable surrogate outcome as a
clinical tool or as an end-point in clinical trials in
1-year-old infants with cystic ﬁbrosis (CF)
diagnosed by newborn screening?
What is the bottom line?
No, because structural changes detected on chest
CT were generally very mild and, with the
exception of air trapping, inter and intraobserver
agreements on CT scores were poor using the
standard Brody-II scoring system.
Why read on?
Chest CT is of questionable value in infants of this
age and thus should not be used routinely;
development of an improved scoring system for
use in mild CF disease is urgent.
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Team for CF (AREST-CF), in order to standardise data collec-
tion. In the absence of any validated scoring system for use in
NBS infants with CF, the Brody-II system was selected. We
hypothesised that signiﬁcant changes would be detected by
1 year of age but that interobserver agreement using Brody-II
would be lower in NBS infants with CF than in older children,
owing to the greater proportion of subjects with no, or only
subtle, abnormalities.2 15
The aims of this study were to (a) standardise CT data collec-
tion across multiple sites to achieve consistent data quality with
an acceptable radiation exposure, (b) ascertain the incidence of
bronchial dilatation and air trapping in NBS infants with CF at
1 year and (c) assess the reproducibility of Brody-II in such
infants by measuring inter- and intraobserver agreement of
scores.
SUBJECTS AND METHODS
Study subjects
NBS infants with CF born between 2009 and 2011 were
referred by one of six specialist LCFC centres for this study.17 18
Chest CT scanning under general anaesthesia (GA) was per-
formed at three of these centres using standardised protocols at
∼1 year of age as part of the study protocol. The study was
approved by the North Thames multicentre research ethics com-
mittee (#09/HO71/314). Informed written parental consent
was obtained (section 1, see online supplementary data).
Protocol for controlled ventilation during GA
Infants were intubated and ventilated (section 2, see online sup-
plementary data). Atelectasis was minimised by using slow inﬂa-
tions to a peak inspiratory pressure (PIP) of ∼35 cmH2O while
maintaining a positive expiratory pressure (PEEP) of
5 cmH2O
19 before the scan. Inspiratory scans were obtained
during a breath-hold at 25 cmH2O PIP, and expiratory scans at
0 cmH2O. Initial adherence to protocols was variable across
centres. Consequently, a team member monitored ventilation
(see online supplementary table E3) using the NICO2 respira-
tory monitor (Philips Respironics, USA).20 (see online supple-
mentary ﬁgure E3 and ﬁgure E4.)
Thin-section CT scan protocol
CT scans were performed using multidetector CT units (see
online supplementary table E1). A predetermined technique for
volumetric CT image acquisition was used (see online supple-
mentary table E2; section 3, see online supplementary data).
Scanning ranges for inspiratory and expiratory scans were tai-
lored for each infant. The planned radiation dose range for the
entire scan was ≤2.0 mSv with a target of ∼1.5 mSv (annual
background radiation exposure in the UK ∼2.5 mSv).21–23
Scoring methodology
CT data collection was completed and scans anonymised before
starting scoring. Studies were scored independently without
clinical or laboratory information by two scorers (AB: 25 years’
paediatric chest CT experience, 13 years’ scoring CF lung
disease; AC: 7 years’ paediatric chest CT experience, 5 years’
scoring CF lung disease) using Brody-II scores.2 12 Using this
scoring system, comprising ﬁve components, the maximum pos-
sible subscore is 72 for bronchial dilatation, 27 for air trapping
and 243 for total CT; higher scores indicating more severe
disease.12 (see online supplementary ﬁgures E1 and E2)
The two scorers scored 12 training scans provided by
AREST-CF, undertaken with similar protocols in young children
with CF aged 1–4 years.5–7 These ‘training scans’ were scored in
two batches of six (section 7, see online supplementary data).
Scoring of LCFC scans took place within 6 weeks of completing
training; scores from both observers being analysed and com-
pared by LPT who was not involved in scoring. LCFC scans
with discrepant subscores were returned to both scorers
(without details of prior scores allocated) for subsequent
reassessment to investigate whether closer agreement might be
achieved (section 7, see online supplementary data). A selection
of LCFC scans was completely rescored after ∼8 months to
assess inter- and intraobserver agreement over time.
Statistical analysis
Data were inspected for distribution (PASW Statistics V.18,
Chicago, Illinois, USA) and summarised using number (percent-
age), mean (SD) or median (IQR) as appropriate. Agreement
between observers was assessed using Cohen’s κ statistic with
linear weighting (MedCal for Windows, statistical software
V.12.3.0, Mariakerke, Belgium). κ Coefﬁcients were similar
whether analysed as non-weighted (results not shown) or with
linear weighting. κ Results were interpreted as 0–0.2: poor
agreement; 0.21–0.4: fair agreement; 0.41–0.6: moderate agree-
ment; 0.61–0.8: strong agreement; 0.81–1.0: excellent agree-
ment.24 Ventilatory pressures and radiation doses between the
centres were compared using Kruskal–Wallis with post hoc com-
parison using Mann–Whitney U tests; adjusted for multiple
comparisons so that the family-wise error rate remained at 0.05.
RESULTS
Patient population
The study was conducted between January 2009 and May
201217 18 25; chest CT scans at 1 year were performed in 65
NBS LCFC infants. Table 1 summarises clinical details of the
infants. At the time of chest CT, all infants were clinically well
with no respiratory symptoms.
Veriﬁcation of adherence to protocols
PEEP during the recruitment inﬂations was slightly higher than
intended (overall median (95% CI) PEEP 7.2 (5.4 to 8.8)
cmH2O, and was signiﬁcantly higher in centre B than C
(p=0.012; see online supplementary table E4). PIP during inﬂa-
tion manoeuvres and end-inspiratory breath-hold was close to
protocol speciﬁcations, with no signiﬁcant differences between
centres.
Radiation doses
Median effective radiation exposure across all centres was 1.5
(1.2 to 1.8) mSv, with centres A and B achieving median doses
close to the target dose of 1.5 mSv; exposure was signiﬁcantly
higher at centre C (see online supplementary ﬁgure E5 and
table E5; overall Kruskal–Wallis p<0.0001). Exposures of
≤1.5 mSv were achieved in 58% of infants; 79% received an
effective dose of ≤2 mSv. Three infants in centre C received
≥3 mSv; two owing to suboptimal positioning.
Training scan scoring
Interobserver agreement was, on average, fair for bronchial dilata-
tion during training batch 1 (κ=0.27 (95% CI 0.08 to 0.46)) and,
after a video conference to discuss discrepancies, moderate for
training batch 2 (κ=0.45 (0.17 to 0.72)). During both training ses-
sions greatest agreement was observed for air trapping (κ=0.82
(0.68 to 0.95) for training batch 1 and 0.79 (0.67 to 0.92) for
batch 2) (see online supplementary table E6 and ﬁgure E6).
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LCFC scan scoring
The ﬁrst round of scoring the LCFC scans (initial LCFC, n=65)
started within 6 weeks of training and was completed within a
month. Complete rescoring of a selected subset of LCFC scans
(rescoring LCFC; n=22) occurred ∼8 months after the initial
scoring. As can be seen from table 2, changes were generally
very mild, with only seven (11%) infants having a total CT score
≥12 (ie, ≥5% of maximum possible Brody score) according to
scorer B, and only two (3%) according to scorer A.
Interobserver agreement between initial and rescoring
LCFC rounds
Although discrepancies between scorers with respect to at least
one subscore occurred in 50/65 scans, 90% of differences were
between a score of 0 (normal), and 1 (minimal to mild disease)
(table 2). There was fair agreement for bronchial dilatation and
strong agreement for air trapping, both during initial scoring of all
65 LCFC scans and when rescoring (table 3). Scans selected for
rescore were representative of those from the entire cohort for the
number and severity of changes detected on CT (ﬁgure 1).
Scorer B identiﬁed more infants with CT changes and gener-
ally allocated higher scores than scorer A during initial scoring
of LCFC scans, the reverse of that seen during training (see
online supplementary ﬁgure E6). Scores for air trapping and
total score were more similar between scorers during rescoring
(ﬁgure 1). κ agreement between scorers was initially only fair
for bronchial dilatation, with minimal improvement during
rescoring, but agreement about the presence or absence of
bronchial dilatation or air trapping was consistently achieved in
>80% of the scans on initial and rescoring rounds (see online
supplementary table E7).
Intraobserver agreement between study rounds
Intraobserver agreement after ∼8 months was only fair for bron-
chial dilatation (scorer A: κ=0.24 (−0.13 to 0.60); B=0.35
(−0.06 to 0.76)) but strong for air trapping (A: κ=0.72 (0.59 to
0.85); B: κ=0.72 (0.55 to 0.88)). For total CT score, scorer
A showed strong while scorer B showed moderate agreement
(A: κ=0.66 (0.42 to 0.90); B: κ=0.51 (0.29 to 0.73)) (see
online supplementary ﬁgure E7). Both scorers detected an iden-
tical proportion of changes when rescoring but those identiﬁed
were not necessarily for the same infants. Challenges were faced
in discriminating between very mild changes potentially attribut-
able to bronchial dilatation or airtrapping and normal, even by
those with considerable expertise, is illustrated in ﬁgure 2.
DISCUSSION
This is the ﬁrst study speciﬁcally to assess the reproducibility,
and hence validity, of CT evaluation of lung disease in infants
with CF. Despite the scoring being undertaken by experienced
observers with prior training, with the exception of air trapping,
the Brody-II score was not reproducible in this age range. The
obvious interpretation of these results is that the mild nature of
any CT changes at 1 year of age precluded reproducible evalu-
ation of most parameters. A label of bronchial dilatation in the
presence of very mild lung disease should therefore be applied
cautiously, at least using current methods and deﬁnitions. These
ﬁndings, together with the technical difﬁculties in standardising
acquisition of CT scans across sites, suggest that the use of CT
both clinically and as an endpoint in multicentre trials of infants
remains extremely challenging.
Strengths and limitations of the study
Standardised protocols for GA, scanning parameters and image
acquisition were established to ensure consistent, reliable CT data
were obtained between centres. This is the ﬁrst study to monitor
adherence to a speciﬁc CT ventilation protocol objectively. Use of
both inspiratory and expiratory volumetric scans to evaluate lung
disease (the ﬁrst such study in NBS infants with CF at 1 year28 29)
reduces the risk of missing subtle abnormalities, thereby increasing
the likely accuracy of the reported changes.
We evaluated Brody-II in infants, as previously undertaken in
older subjects with CF, by measuring inter- and intra-agreement
of scores by two highly experienced scorers, who underwent
training using scans from young children with CF immediately
before scoring the LCFC scans in an attempt to ensure consist-
ent interpretation.
The main limitation, as with similar studies, was the lack of
normal CT scans for comparison owing to concerns about radi-
ation exposure in healthy individuals. Since clinical CT scans in
children with normal lungs (eg, screening for metastases) would
not include expiratory images, even this group would not
provide adequate controls. In addition, at the time of study, few
training scans from 1-year-old NBS infants with CF were avail-
able. Owing to the time-consuming nature of the reproducibility
studies, no other CT scoring system was used, but given that
most use components which at least overlap with Brody-II, it is
unlikely that the results would have been very different.
Radiological evidence of structural lung disease
Although AREST-CF detected structural abnormalities in 81%
of NBS infants with CF at a median age of 3.6 months,
Table 1 Clinical features of infants with NBS-diagnosed CF undergoing CT at
1 year of age
Features Value
N (% boys) 65 (48)
Age at diagnosis, weeks* 3.4 (3.0−4.4)
Pancreatic insufficiency, n (%) 61 (94)
Meconium ileus, n (%) 7 (11)
Delta F508†, n (%) 58 (89)
Age at time of test, weeks 52.7 (4.7)
Somatic growth
Weight, z score‡ 0.34 (0.10)
Length, z score‡ 0.49 (0.97)
Body mass index, z score‡ 0.09 (0.84)
Before 1 year CT assessments
Respiratory symptoms, ever:
Wheeze, physician-diagnosed 22 (34)
Crackles, physician-diagnosed 7 (11)
Bacterial growth on cough swab, ever§
Pseudomonas aeruginosa¶ 20 (31)
Other significant bacterial growth** 24 (37)
No growth†† 21 (32)
Results expressed as mean (SD) or n (%) unless otherwise stated.
*Median (IQR).
†Homozygous or heterozygous.
‡Calculated according to Cole et al.26
§Based on the presence of bacteria ever isolated in the first year.
¶Definition of colonisation according to Lee et al27; only 2/65 (3%) infants had any
evidence of Pseudomonas aeruginosa (PsA) on bronchoalveolar lavage or cough
swab within 5 days of the CT scan.
**Significant bacterial growth consisted of those who had methicillin-sensitive or
methicillin-resistant Staphylococcus aureus (MSSA or MRSA, respectively),
Haemophilus influenza (HI), Stenotrophomonas maltophilia, Acromobacter xylosidans
or Aspergillus fumigatus with no previous growth of PsA.
††No bacterial growth consisted of those with isolation of coliforms and upper
respiratory tract flora only.
CF, cystic fibrosis; NBS, newborn screened.
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bronchial dilatation was only found in 11/57 (19%) at this age,6
and remained low through the ﬁrst 2 years of life (∼8% at both
1 and 2 years of age) before increasing markedly to ∼36% by
4 years.7 In the most recent publication from this group, preva-
lence of bronchial dilatation in children with CF during the ﬁrst
4 years of life was ∼60%,10 ∼80% of whom had evidence of
bronchial dilatation at some time during the ﬁrst 3 years.
Bronchiectasis as classically deﬁned refers to irreversible dilata-
tion due to damaged bronchi. The ‘apparent improvement’ in
bronchiectasis reported in some of the AREST children with CF
Table 2 Interobserver agreement for CT scores allocated to infants with NBS-diagnosed CF at 1 year of age during initial scoring of LCFC scans (n=65)
(a) Bronchial dilatation (maximum possible score=72)
κ=0.21 (0.05; 0.37) Scorer A
0 1 2 3 4 5
Scorer B
0 48 – – – –
1 6 – – – – –
2 4 3 1 – – –
3 1 – – – – –
4 1 – – – – –
5 – 1 – – – –
(b) Air trapping (maximum possible score=27)
κ=0.66 (0.49; 0.83) Scorer A
0 1 2 3 4 5 7 8 15 16
Scorer B
0 37 – 1 – – – – – – –
1 6 3 – – – – – – – –
2 3 – 1 1 – – – – – –
3 1 1 1 2 – – – – – –
4 – – – – 2 – – – – –
5 – – – – 2 – – – – –
7 – – – – – 1 – – – –
8 1 – – 1 – – – – – –
15 – – – – – – – – – 1
16 – – – – – – – – – –
(c) Total CT score (maximum possible score=243)
κ=0.34 (0.20 to 0.49) Scorer A
0 1 2 3 4 5 6 7 8 9 10 12 13 14 17 19 25 30
Scorer B
0 7 – – – – – – – – – – – – – – – – –
1 5 5 – – – – – – – – – – – – – – – –
2 7 1 – – – – – – – – – – – – – – – –
3 5 – 2 1 – – – – – – – – – – – – – –
4 3 1 – 2 – 1 – – – – – – – – – – – –
5 – 4 1 1 – 1 – – – – – – – – – – – –
6 1 – 1 – 1 – – – – – – – – – – – – –
7 1 1 1 – – 1 – – – – – – – – – – – –
8 1 – – 1 – – – – – – – – – – – – – –
9 – – – – 1 – – – – – – – – – – – – –
10 – – – – – – – – – – 1 – – – – – – –
12 – – – – – 1 – – – – – – – – – – – –
13 – – – – – 2 – – – – – – – – – – – –
14 1 – – – – – – – – – – – – – – – – –
17 – – – – – – – 1 – – – – – – – – – –
19 – – – – – – – – – – – 1 – – – – – –
25 – – – – – – – – – – – – – – – – – –
30 – – – – – – – – – – – – – – – – 1 –
Shaded cells across the diagonals within each table represent identical results by scorers A and B using the Brody-II scoring system. For air trapping scores >5 and total CT scores >12,
only those for which any values were obtained are shown. Although scorer B identified more abnormalities on scans than scorer A as indicated by values generally falling below the
shaded diagonal cells (17 (26%) vs 5 (7%) for bronchial dilatation; 27 (42%) vs 17 (26%) for air trapping, the severity of changes were generally very minor, with only seven (11%)
and two (3%) of patients having a total CT score ≥12 or 5% of the total possible score). κ=κ coefficient (95% CI) as a measure of agreement of CT subscores and total scores
allocated by scorer A and B. It can be seen that the majority of discrepancies for bronchodilatation occurred when changes were deemed to be very minor(1–3) by one scorer and absent
[0] by the other.
LCFC, London Cystic Fibrosis Collaboration; NBS, newborn screened.
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might be associated with mild and borderline normal bronchi
(see below). The AREST-CF studies also report more air trap-
ping (67% at ∼4 months,6 62% at ∼1 year7 and 69% at
∼3 years10) than in this study. These discrepancies may be par-
tially explained by the fact that in contrast to the AREST-CF
study, LCFC children were only studied when asymptomatic.
Bronchial dilatation was signiﬁcantly more likely (60.0% vs
10.2% in asymptomatic) and more severe in AREST infants
with CF with respiratory symptoms at the time of CT.6
Use of different scoring systems makes direct comparisons dif-
ﬁcult, particularly when attempting to quantify severity of
changes. While changes could be identiﬁed on at least one
Brody-II subscore in 34/65 (52%) of the LCFC infants, the mag-
nitude of these changes was often trivial. Important changes
(deﬁned either by visual inspection and/or a total CT score ≥5%
maximum possible) were only detected in 2% of infants by
scorer A and 11% by scorer B (table 2).
Comparing inter- and intraobserver agreement of CT scores
with other studies
The interobserver agreement when using Brody-II in NBS
infants with CF contrasts with previous studies in older subjects
Figure 1 Interobserver agreement
between initial and rescoring London
Cystic Fibrosis Collaboration (LCFC)
rounds. CT scores were allocated by
scorers A and B for the subset of 22
scans during initial and rescoring
rounds. While all 22 pairs of results
have been plotted, overlap of some
data, particularly those with zero
scores means that not all results can
be identiﬁed individually. Bold circles
represent data that overlaid each
other, the number in brackets
representing the number of infants
with each combination of scores.
During initial scoring of the subset,
scores allocated by scorer B were
generally higher than those by scorer
A for bronchial dilatation and total
scores (A and C). More consistent
scores with good agreement were seen
for air trapping (B). During rescoring of
this subset, scores were more similar,
although only fair agreement was
again seen for bronchial dilatation (D),
while good agreement was seen for air
trapping and total scores (E and F).
κ=κ coefﬁcient (95% CI). AT, air
trapping, BD, bronchial dilatation.
Table 3 κ Values between both scorers during the initial LCFC scoring round of the entire LCFC cohort, (n=65) and during initial and repeat scoring rounds of the subset
of 22 scans
Initial scoring
(entire cohort:
n=65)
Initial scoring*
(subset: n=22)
Rescoring*
(n=22)
Bronchial dilatation 0.21 (0.05 to 0.37) 0.38 (0.01 to 0.76) 0.24 (−0.27 to 0.75)
Air trapping 0.66 (0.49 to 0.83) 0.58 (0.37 to 0.79) 0.80 (0.67 to 0.93)
Total CT scores 0.34 (0.20 to 0.49) 0.38 (0.13 to 0.62) 0.67 (0.48 to 0.86)
Results presented as mean (95% CI) linear weighted κ coefficient.
*Scans from 22/65 LCFC infants were selected, results of which are summarised both for initial values and after rescoring.
LCFC, London Cystic Fibrosis Collaboration.
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(including those in which scorers A and B participated, see
online supplementary table E8). Previous studies have found
that bronchial dilatation is the most reliably reproducible
element when evaluating CF lung disease.12 15 30 The relatively
poor agreement in this study probably reﬂects the subtlety of
changes seen. A single scorer scored all the AREST-CF scans
with good intraobserver agreement after a 6–12-month interval7
(see online supplementary table E8). Separate assessments for
younger children in whom bronchial dilatation was infrequent
and milder were not, however, reported. While use of a single
dedicated observer to score all scans6 7 9 might provide more
consistent outcomes, such an approach is impractical in clinical
practice and unlikely to be either generalisable or feasible in
large multicentre trials. In the absence of measures of repeatabil-
ity, the extent to which inter- and intraobserver variation contri-
butes to the reported CT ﬁndings cannot be established.
Deﬁnition of bronchial dilatation
Additional problems in interpreting CT scans relate to lack of
international consensus on how to deﬁne bronchial dilatation,
especially in infants. A bronchoarterial ratio (BAR) >1 as speci-
ﬁed in Brody-II was used both in this study and CF-AREST.
This speeds up evaluation, as judging whether the bronchus is
bigger than the adjoining vessel can be assessed subjectively
more easily than calculating a ratio. It has been suggested that a
threshold of 0.76, rather than 1, should be applied in chil-
dren,31 32 but given the poor inter- and intraobserver agreement
even when using BAR≥1 in infants with mild CF lung disease, it
is unlikely that this would be effective. Furthermore, measuring
changes in small bronchial luminal size to deﬁne bronchial dila-
tation may be beyond current CT spatial resolving ability. The
accuracy of assessing BARs, especially in health, is also critically
dependent on reliably achieving full lung inﬂations.33
Technical challenges in acquiring standardised CTs
We experienced several challenges in performing thoracic CT in
this age group. Despite clear protocols and brieﬁng the anaes-
thetic and radiology teams across all centres, variability in the
image acquisition parameters—namely, airway pressures and
radiation doses delivered was seen. The greater variability in
radiation doses in centre C might be due to their slightly differ-
ent type of scanner (see online supplementary table E1) and/or
the fact that it was not possible to organise a dedicated radiog-
rapher to perform procedures within that hospital, the latter
being a problem likely to be found in clinical practice as well as
multicentre trials. The presence of an investigator to monitor all
procedures improved compliance, but is unlikely to be feasible
in clinical practice or most clinical trials.
To date there is no consensus on the optimal method of
acquiring CT scans in young children to ensure maximum infor-
mation with minimal radiation exposure. After discussions with
the AREST-CF team, we adopted their approach of obtaining
end-inspiratory scans at 25 cmH2O PIP, and end-expiratory
scans at 0 cmH2O, together with recruitment manoeuvres to
minimise procedure-related atelectasis. However, whereas we
used a volumetric technique that images the entire lung volume,
initial studies by AREST-CF consisted of three thin-slice scans
during inspiration and expiration.6 7 9 Limiting the dataset to
three images, compared with ≥20 for the volumetric technique,
severely limits the number of airways that can be evaluated. In
addition, if bronchi were sampled and imaged at the point of
bifurcation, this would overestimate the size of the bronchial
lumen, potentially leading to overdetection of bronchial
dilatation.
Clinical implications
Results from this study suggest that both the acquisition and
interpretation of CT scans need further evaluation before being
applicable either as a research outcome measure or clinical tool
in NBS infants with CF at least at 1 year of age. Based on the
incidence of bronchial dilatation detected by both scorers in this
study, between 190 and 850 infants per group would be
required if a randomised trial such as the recent Ivacaftor trial34
were to be extended to infants, in order to detect a reduction in
bronchial dilatation of 50% with 90% power at a 5% signiﬁ-
cance level at 1 year of age; this number would rise further after
accounting for those ineligible for such a trial or whose parents
decline.35 Suggestions that such a study would be feasible with
only 100/group were based on the incidence of bronchiectasis at
4, not 1 year of age.7 Since there is neither knowledge about the
long-term clinical signiﬁcance of mild changes detected in
young infants with CF, nor any data to suggest that mild
changes lead to alterations in clinical management or long-term
clinical outcomes, it is questionable whether the risks of expos-
ing young infants to additional ionising radiation outweigh the
beneﬁts. Indeed, as a result of this study, without speciﬁc clinical
indications, chest CTs are no longer performed in NBS infants
with CF at 1 year within the LCFC group.
FUTURE DIRECTIONS
Before chest CT can be advocated for widespread use, especially
in very young children, standardised CT scanning protocols,
which demonstrably can be used in multiple centres, in combin-
ation with a reproducible scoring system with good intra- and
interobserver agreement, are essential. Given the radiation
burden and the expense of even limited, low-dose annual CT
scans, it is essential to ensure that the information obtained is
Figure 2 Examples of CT images from infants with cystic ﬁbrosis (CF)
showing mild abnormalities in bronchial dilatation and air trapping
leading to discrepancy in scoring. (A) An example of thin section CT of
the left lung in an infant with CF taken at 1 year of age showing
discrepancies in scoring bronchial dilatation (circled). This was scored
as normal by scorer A, but mild by scorer B during the initial study
round, whereas during the subsequent rescoring round ∼ 8 months
later, scorer A scored this as mild bronchial dilatation, while scorer B
scored it as normal. (B) Subtle tiny areas of hyperlucency in some of
the scattered secondary pulmonary lobules of the lower lobes in
keeping with air trapping (ringed by oval). During the initial scoring
round, scorer A scored this as mild air trapping while scorer B labelled
it as no air trapping. During the rescoring round, both scorers allocated
mild air trapping.
6 Thia LP, et al. Thorax 2013;0:1–8. doi:10.1136/thoraxjnl-2013-204176
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useful; indeed there is a strong case for a randomised controlled
study of whether CT improves outcome, analogous to the
recent Australasian bronchoscopy study.36 A more robust
approach to CT scoring in infants with CF, in whom changes
may be very mild, may be required; current relatively subjective
methods could be augmented by publishing visual standards for
comparison or by the more widespread use of formal airway
measurements and quantitative assessment of air trapping.37
In conclusion, we do not believe that CT is ready for wide-
spread clinical use or as a trial endpoint in the ﬁrst year of life
for NBS infants with CF. Until reﬁnement of CT scoring has
been established and validated, we recommend caution in
reporting bronchial dilatation in NBS infants with CF, the inci-
dence of which appears to be low in the ﬁrst year of life.
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